Published in J Biol Chem on October 06, 1995
Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol (1998) 2.00
The alpha chain of laminin-1 is independently secreted and drives secretion of its beta- and gamma-chain partners. Proc Natl Acad Sci U S A (1997) 1.61
Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J Biol Chem (2006) 1.55
In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci U S A (2001) 1.48
IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. Mamm Genome (1997) 1.17
Laminin deposition in the extracellular matrix: a complex picture emerges. J Cell Sci (2009) 1.14
Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration. J Cell Sci (2001) 1.12
Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol (1996) 1.10
Laminin 332 processing impacts cellular behavior. Cell Adh Migr (2012) 1.02
Laminin-332-beta1 integrin interactions negatively regulate invadopodia. J Cell Physiol (2010) 0.98
Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells. Histochem Cell Biol (2008) 0.94
Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia (2004) 0.92
LAMC2 enhances the metastatic potential of lung adenocarcinoma. Cell Death Differ (2015) 0.88
MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma. Am J Pathol (2012) 0.87
Upregulation of gamma-2 laminin-332 in the mouse ear vesicant wound model. J Biochem Mol Toxicol (2009) 0.84
Topical application of laminin-332 to diabetic mouse wounds. J Dermatol Sci (2007) 0.84
Extent of laminin-5 assembly and secretion effect junctional epidermolysis bullosa phenotype. J Exp Med (1998) 0.82
N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc. J Biol Chem (2008) 0.81
Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro. J Invest Dermatol (2007) 0.81
Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2. Mol Cancer (2010) 0.80
Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions. J Invest Dermatol (2006) 0.79
Distribution of basement membrane anchoring molecules in normal and transformed endometrium: altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas. J Mol Histol (2004) 0.78
A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.78
Fluorescently tagged laminin subunits facilitate analyses of the properties, assembly and processing of laminins in live and fixed lung epithelial cells and keratinocytes. Matrix Biol (2008) 0.76
Gene therapy for a lethal genetic blistering disease: a status report. Trans Am Clin Climatol Assoc (1999) 0.75
Sulfur mustard-stimulated proteases and their inhibitors in a cultured normal human epidermal keratinocytes model: A potential approach for anti-vesicant drug development. Toxicol Rep (2016) 0.75
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 4.06
Cloning and structure of a yeast gene encoding a general transcription initiation factor TFIID that binds to the TATA box. Nature (1989) 3.74
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature (1980) 3.44
Enhancement of RNA polymerase III transcription by the E1A gene product of adenovirus. Cell (1985) 3.21
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol (2006) 2.56
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol (1992) 2.14
Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Cloning of the Schizosaccharomyces pombe TFIID gene reveals a strong conservation of functional domains present in Saccharomyces cerevisiae TFIID. Genes Dev (1990) 1.90
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A (1987) 1.89
Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73
Purification of a yeast TATA box-binding protein that exhibits human transcription factor IID activity. Proc Natl Acad Sci U S A (1989) 1.70
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65
Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. N Engl J Med (1980) 1.58
Calibration and characterization of beta-particle sources for intravascular brachytherapy. Med Phys (1998) 1.48
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
A filtration method for improving film dosimetry in photon radiation therapy. Med Phys (1997) 1.46
A new approach to film dosimetry for high energy photon beams: lateral scatter filtering. Med Phys (1997) 1.39
Enzyme-linked immunosorbent assay for human skin collagenase. Coll Relat Res (1983) 1.38
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
Kinetic studies of calcium binding to the regulatory site of troponin C from cardiac muscle. J Biol Chem (1996) 1.37
Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol (1977) 1.33
Human skin collagenase. The role of serum alpha-globulins in the control of activity in vivo and in vitro. Proc Natl Acad Sci U S A (1971) 1.31
Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure-function studies of TFIIE-alpha. Mol Cell Biol (1995) 1.30
Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics (1994) 1.28
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum (1995) 1.28
Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp Cell Res (2000) 1.27
The conserved carboxy-terminal domain of Saccharomyces cerevisiae TFIID is sufficient to support normal cell growth. Mol Cell Biol (1991) 1.25
Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. J Biol Chem (1993) 1.21
Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. J Invest Dermatol (1992) 1.20
Trunk exercise combined with spinal manipulative or NSAID therapy for chronic low back pain: a randomized, observer-blinded clinical trial. J Manipulative Physiol Ther (1997) 1.15
Laminin-5 inhibits human keratinocyte migration. Exp Cell Res (1997) 1.15
Isotretinoin treatment of Darier's disease. J Am Acad Dermatol (1982) 1.13
Animal and human collagenases. J Invest Dermatol (1970) 1.12
Studies on purified rheumatoid synovial collagenase in vitro and in vivo. J Clin Invest (1971) 1.12
A kinetic model for the binding of Ca2+ to the regulatory site of troponin from cardiac muscle. J Biol Chem (1997) 1.11
Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem (1989) 1.11
Collagenase in human cornea: immunologic localization. Arch Ophthalmol (1980) 1.09
Recessive dystrophic epidermolysis bullosa: evidence for an altered collagenase in fibroblast cultures. Proc Natl Acad Sci U S A (1977) 1.07
Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab (2000) 1.07
Effectiveness, side effects and long-term status of nightguard vital bleaching. J Am Dent Assoc (1994) 1.07
Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol (1993) 1.07
Families need help too: group treatment for families of nursing home residents. Clin Nurse Spec (1993) 1.06
Resolution of end-to-end distance distributions of flexible molecules using quenching-induced variations of the Forster distance for fluorescence energy transfer. Biophys J (1988) 1.06
Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol (1980) 1.06
The role of human skin collagenase in epidermolysis bullosa. J Invest Dermatol (1977) 1.05
Distance distributions and anisotropy decays of troponin C and its complex with troponin I. Biochemistry (1991) 1.04
Immunologic relationship of a purified human skin collagenase to other human and animal collagenases. Biochim Biophys Acta (1970) 1.04
Radioimmunoassay of human collagenase. Specificity of the assay and quantitative determination of in vivo and in vitro human skin collagenase. J Biol Chem (1972) 1.03
Recessive dystrophic epidermolysis bullosa. Evidence for increased collagenase as a genetic characteristic in cell culture. J Exp Med (1978) 1.03
Distance distributions in proteins recovered by using frequency-domain fluorometry. Applications to troponin I and its complex with troponin C. Biochemistry (1988) 1.03
Characterization of procollagen synthesized by matrix-free cells isolated from chick embryo tendons. Biochemistry (1976) 1.02
Conformational changes in guanylyl cyclase-activating protein 1 (GCAP1) and its tryptophan mutants as a function of calcium concentration. J Biol Chem (1999) 1.02
Inhibition of collagen degradative enzymes by retinoic acid in vitro. J Am Acad Dermatol (1982) 1.02
Enhanced collagenase production by fibroblasts derived from human basal cell carcinomas. Cancer Res (1979) 1.02
Coupling of calcium to the interaction of troponin I with troponin C from cardiac muscle. Biochemistry (1994) 1.00
Biosynthesis of collagenase by human skin fibroblasts in monolayer culture. J Biol Chem (1979) 1.00
Preparation of three vertebrate collagenases in pure form. Biochem Biophys Res Commun (1971) 0.99
Decreased collagenase production by regional fibroblasts cultured from skin of a patient with connective tissue nevi of the collagen type. J Invest Dermatol (1982) 0.99
MR cholangiography in the evaluation of neonatal cholestasis. Radiology (1999) 0.98
Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol (1992) 0.97
Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma. J Biol Chem (1991) 0.97
Gamma 2 chain of laminin-5 is recognized by monoclonal antibody GB3. J Invest Dermatol (1995) 0.97
Alternative pathways and reactions of benzyl alcohol and benzaldehyde with horse liver alcohol dehydrogenase. Biochemistry (1993) 0.96
Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology. J Invest Dermatol (1986) 0.96
The structure of the human skin fibroblast collagenase gene. J Biol Chem (1988) 0.95
Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures. J Clin Invest (1982) 0.94
Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain. Nucleic Acids Res (1994) 0.94
Proximity relationship in the binary complex formed between troponin I and troponin C. J Mol Biol (1986) 0.93
Focal dermal hypoplasia: abnormal growth characteristics of skin fibroblasts in culture. J Invest Dermatol (1980) 0.93
Regulation of vertebrate collagenase activity in vivo and in vitro. J Invest Dermatol (1972) 0.93
Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method. Am J Clin Pathol (1993) 0.93
Collagenase expression in skin fibroblasts from families with recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1989) 0.92
Disparate fluorescence properties of 2-[4'-(iodoacetamido)anilino]-naphthalene-6-sulfonic acid attached to Cys-84 and Cys-35 of troponin C in cardiac muscle troponin. Biophys J (1997) 0.92
Upper airway and external genital involvement in epidermolysis bullosa dystrophica. Radiology (1982) 0.91
Expression of HSP70 in healing wounds of diabetic and nondiabetic mice. J Surg Res (1999) 0.91
Cell culture density as a modulator of collagenase expression in normal human fibroblast cultures. Exp Cell Res (1977) 0.90
Enhanced cell-free translation of human skin collagenase in recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1982) 0.90
Quantitation of vital bleaching by computer analysis of photographic images. J Am Dent Assoc (1999) 0.89
Tissue stress and tumor promotion. Possible relevance to epidermolysis bullosa. Arch Dermatol (1988) 0.89
The mechanobullous diseases. Dermatol Clin (1987) 0.89
Role of the extracellular matrix in the degradation of connective tissue. Arch Dermatol Res (1994) 0.89
Utero-tubal transfer of mouse embryos. Genesis (2001) 0.89
Symposium on epidermolysis bullosa: molecular biology and pathology of the cutaneous basement membrane zone. Jefferson Medical College, Philadelphia, Pennsylvania, October 4 and 5, 1991. J Invest Dermatol (1992) 0.89
Distance distributions in native and random-coil troponin I from frequency-domain measurements of fluorescence energy transfer. Biopolymers (1988) 0.88
Characterization of troponin-C interactions in skinned barnacle muscle: comparison with troponin-C from rabbit striated muscle. J Muscle Res Cell Motil (1997) 0.88
Stimulation of skin fibroblast collagenase production by a cytokine derived from basal cell carcinomas. J Invest Dermatol (1985) 0.88
Enhanced biosynthesis of human skin collagenase in fibroblast cultures from recessive dystrophic epidermolysis bullosa. J Clin Invest (1980) 0.87
Basal cell carcinoma and collagenase. J Dermatol Surg Oncol (1986) 0.87
Interactions of troponin subunits: free energy of binary and ternary complexes. Biochemistry (1987) 0.87
Time-resolved tryptophan emission study of cardiac troponin I. Biophys J (1992) 0.87